Jun 4, 2026 06:40AM
May 4, 2026 07:33AM
Jan 20, 2026 06:39AM
Jan 5, 2026 06:40AM
Aug 22, 2025 06:53AM
Jun 10, 2025 06:39AM
Jun 2, 2025 06:45AM H.C. Wainwright Reiterates Buy Rating on Axsome Therapeutics (AXSM)
May 7, 2025 07:16AM
Mar 6, 2025 06:54AM
Feb 11, 2025 06:43AM
Jan 31, 2025 06:41AM
Jan 21, 2025 06:41AM
Dec 31, 2024 06:32AM
Nov 25, 2024 06:43AM H.C. Wainwright Reiterates Buy Rating on Axsome Therapeutics (AXSM)
Sep 5, 2024 06:48AM
Aug 6, 2024 06:40AM
Sep 5, 2023 07:00AM
Jun 30, 2023 04:02PM
Jun 28, 2023 09:29AM
Jun 28, 2023 09:28AM
Sep 3, 2020 07:00AM Axsome Therapeutics to Present at Upcoming Investor Conferences
Sep 3, 2020 07:00AM
Dec 30, 2019 08:55AM
Dec 23, 2019 04:19PM
Dec 23, 2019 04:19PM
Dec 19, 2019 07:06AM
Dec 19, 2019 07:05AM
Dec 19, 2019 07:05AM Axsome Therapeutics Announces Pricing of Public Offering of $174 Million of Shares of Common Stock
Dec 17, 2019 09:19AM
May 6, 2019 09:28AM
Dec 10, 2018 09:28AM
Aug 28, 2018 07:00AM
Aug 28, 2018 07:00AM
Jun 7, 2018 09:29AM
Jun 7, 2018 07:33AM UPDATE: H.C. Wainwright Starts Axsome Therapeutics (AXSM) at Buy
Mar 26, 2018 07:00AM
Mar 26, 2018 07:00AM
Dec 6, 2017 07:00AM
Dec 1, 2017 07:04AM
Dec 1, 2017 07:00AM

21,328 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All